{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:14:09Z","timestamp":1783545249138,"version":"3.55.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004008","name":"Istituto Superiore di Sanit\u00e0","doi-asserted-by":"publisher","award":["BFC2"],"award-info":[{"award-number":["BFC2"]}],"id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jneuroim.2022.577935","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T11:53:41Z","timestamp":1659009221000},"page":"577935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis"],"prefix":"10.1016","volume":"371","author":[{"given":"Francesca","family":"Aloisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577935_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","article-title":"Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis","volume":"91","author":"Abrahamyan","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13073-019-0640-z","article-title":"Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility","volume":"11","author":"Afrasiabi","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41598-019-55850-z","article-title":"The interaction of multiple sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis","volume":"10","author":"Afrasiabi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061110","article-title":"Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and multiple sclerosis","volume":"8","author":"Almohmeed","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003220","article-title":"Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis","volume":"9","author":"Angelini","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0030","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3389\/fimmu.2020.00793","article-title":"Cytomegaloviruses and macrophages-friends and foes from early on?","volume":"11","author":"Baasch","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ebiom.2017.01.042","article-title":"Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis","volume":"16","author":"Baker","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41390-019-0591-5","article-title":"The promise of a prophylactic Epstein-Barr virus vaccine","volume":"87","author":"Balfour","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0055","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1172\/JCI128475","article-title":"Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis","volume":"129","author":"Beltran","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0060","doi-asserted-by":"crossref","first-page":"44266","DOI":"10.18632\/oncotarget.17863","article-title":"Leflunomide\/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication","volume":"8","author":"Bilger","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/archneur.1983.04050070036006","article-title":"Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis","volume":"40","author":"Bray","year":"1983","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0075","doi-asserted-by":"crossref","first-page":"E7118","DOI":"10.1073\/pnas.1521644112","article-title":"Human genetic basis of interindividual variability in the course of infection","volume":"112","author":"Casanova","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/imm.12808","article-title":"Programmed death 1 is highly expressed on CD8(+) CD57(+) T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus","volume":"152","author":"Cencioni","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0085","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","article-title":"Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis","volume":"115","author":"Cepok","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(21)00250-7","article-title":"BTK inhibitors as potential therapies for multiple sclerosis","volume":"20","author":"Correale","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.06.029","article-title":"Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients","volume":"180","author":"Cross","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","article-title":"Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis","volume":"70","author":"De Jager","year":"2008","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jneuroim.2022.577935_bb0105","first-page":"CD011487","article-title":"Antiviral agents for infectious mononucleosis (glandular fever)","volume":"12","author":"De Paor","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0115","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1177\/1352458513477231","article-title":"Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis","volume":"19","author":"Disanto","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0120","first-page":"4","article-title":"The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease","volume":"15","author":"Dolei","year":"2009","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","article-title":"The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(15)00313-0","article-title":"The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/13550280490499524","article-title":"Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein","volume":"10","author":"Holm\u00f8y","year":"2004","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0150","doi-asserted-by":"crossref","first-page":"eeav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0155","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/1352458520907901","article-title":"Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors","volume":"26","author":"Jacobs","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0160","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/eji.200939761","article-title":"Intrathecal immune responses to EBV in early MS","volume":"40","author":"Jaqui\u00e9ry","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","article-title":"The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature","volume":"264","author":"Jarius","year":"2017","journal-title":"J. Neurol."},{"issue":"85\u2013100","key":"10.1016\/j.jneuroim.2022.577935_bb0170","article-title":"Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0175","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/brain\/awn108","article-title":"Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis","volume":"131","author":"Jilek","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102332","article-title":"Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model","volume":"106","author":"Jog","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0185","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/brain\/awm214","article-title":"Multiple sclerosis: T-cell receptor expression in distinct brain regions","volume":"130","author":"Junker","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.732694","article-title":"Gender and the sex hormone estradiol affect multiple sclerosis risk gene expression in Epstein-Barr virus-infected B cells","volume":"12","author":"Keane","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103572","article-title":"The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype","volume":"71","author":"Keane","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00747-17","article-title":"Drug modulators of B cell signaling pathways and Epstein-Barr virus lytic activation","volume":"91","author":"Kosowicz","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0205","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1073\/pnas.1901283116","article-title":"pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis","volume":"116","author":"Kremer","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0215","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.35.3.435","article-title":"Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis","volume":"35","author":"Larsen","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0220","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/brain\/awr197","article-title":"Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria","volume":"134","author":"Lassmann","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ane.12417","article-title":"Antivirus immune activity in multiple sclerosis correlates with MRI activity","volume":"133","author":"Latham","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0230","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0235","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0240","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113329","article-title":"Emerging small-molecule inhibitors of the Bruton\u2019s tyrosine kinase (BTK): current development","volume":"217","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0250","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3389\/fimmu.2019.02193","article-title":"The T-cell response to Epstein-Barr virus-new tricks from an old dog","volume":"10","author":"Long","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0255","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.201444662","article-title":"High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells","volume":"44","author":"Lossius","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0260","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2","volume":"205","author":"L\u00fcnemann","year":"2008","journal-title":"J. Exp. Med."},{"issue":"Suppl. 201","key":"10.1016\/j.jneuroim.2022.577935_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ane.12839","article-title":"Trials of antivirals in the treatment of multiple sclerosis","volume":"136","author":"Lycke","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2014.02.013","article-title":"Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients","volume":"270","author":"Mameli","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/tan.12604","article-title":"Human leukocyte antigens and genetic susceptibility to lymphoma","volume":"86","author":"McAulay","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0280","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000001420","article-title":"Epstein-Barr virus genetic variants are associated with multiple sclerosis","volume":"84","author":"Mechelli","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0285","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/eji.202149179","article-title":"HLA-DRB1*15:01 is a co-receptor for Epstein-Barr virus, linking genetic and environmental risk factors for multiple sclerosis","volume":"51","author":"Menegatti","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0290","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel","volume":"17","author":"Munger","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0295","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1352458508100037","article-title":"Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis","volume":"15","author":"Nielsen","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0300","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.0b013e318215286d","article-title":"Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis","volume":"76","author":"Otto","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102501","article-title":"Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens","volume":"9","author":"Pedergnana","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0310","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"Pender","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0315","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2009.01.017","article-title":"Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection","volume":"8","author":"Pender","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0320","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1352458514521888","article-title":"Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis","volume":"20","author":"Pender","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2017.25","article-title":"Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103282","article-title":"The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatment","volume":"56","author":"Pham","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0335","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archneurol.2010.99","article-title":"Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis","volume":"67","author":"Piccio","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0340","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pruss","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119605","article-title":"EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy","volume":"10","author":"Ricigliano","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0350","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/1744666X.2021.1847642","article-title":"The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review","volume":"16","author":"Ruprecht","year":"2020","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0355","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2015.00604","article-title":"Involvement of CD8(+) T cells in multiple sclerosis","volume":"6","author":"Salou","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0360","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0365","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/NEN.0000000000000082","article-title":"Epstein-barr virus in the central nervous system and cervical lymph node of a patient with primary progressive multiple sclerosis","volume":"73","author":"Serafini","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00980-19","article-title":"Epstein-Barr virus-specific CD8 T cells selectively infiltrate the brain in multiple sclerosis and interact locally with virus-infected cells: clue for a virus-driven Immunopathological mechanism","volume":"93","author":"Serafini","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0375","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.0308689100","article-title":"Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood","volume":"101","author":"Skulina","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0380","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6:248ra107","author":"Stern","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0385","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fonc.2013.00299","article-title":"Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers","volume":"3","author":"Su","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0390","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneur.1980.00500510052009","article-title":"Epstein-Barr virus antibodies in multiple sclerosis","volume":"37","author":"Sumaya","year":"1980","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0395","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/gene.2011.42","article-title":"Epstein-Barr virus and multiple sclerosis: interaction with HLA","volume":"13","author":"Sundqvist","year":"2012","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0400","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1352458513494489","article-title":"Cytomegalovirus seropositivity is negatively associated with multiple sclerosis","volume":"20","author":"Sundqvist","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0405","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstrom","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0410","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20161846","article-title":"Human immunity against EBV-lessons from the clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0415","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1073\/pnas.1902623116","article-title":"Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk","volume":"116","author":"Tengvall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0420","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0425","first-page":"151","article-title":"EBV persistence--introducing the virus","volume":"390","author":"Thorley-Lawson","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0430","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/eji.201545921","article-title":"Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients","volume":"46","author":"van Nierop","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1352458515588581","article-title":"Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins","volume":"22","author":"van Nierop","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0440","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","article-title":"Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients","volume":"134","author":"van Nierop","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0445","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(00)00181-8","article-title":"Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis","volume":"105","author":"van Noort","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"174\u201384","key":"10.1016\/j.jneuroim.2022.577935_bb0450","article-title":"Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait","volume":"55","author":"Venkataraman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.665718","article-title":"The CD8 T cell-Epstein-Barr virus-B cell Trialogue: a central issue in multiple sclerosis pathogenesis","volume":"12","author":"Veroni","year":"2021","journal-title":"Front. Immunol."},{"issue":"1264\u201381","key":"10.1016\/j.jneuroim.2022.577935_bb0460","article-title":"HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0465","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11481-020-09948-1","article-title":"Antibodies from multiple sclerosis brain identified Epstein-Barr virus nuclear antigen 1 & 2 epitopes which are recognized by oligoclonal bands","volume":"16","author":"Wang","year":"2021","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0470","doi-asserted-by":"crossref","first-page":"eabf3685","DOI":"10.1126\/scitranslmed.abf3685","article-title":"A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice","volume":"14","author":"Wei","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0475","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fimmu.2015.00600","article-title":"Investigating the antigen specificity of multiple sclerosis central nervous system-derived immunoglobulins","volume":"6","author":"Willis","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577935_bb0480","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2022.577935_bb0485","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.202048655","article-title":"Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15","volume":"51","author":"Zdimerova","year":"2021","journal-title":"Eur. J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:49:29Z","timestamp":1777495769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":97,"alternative-id":["S0165572822001308"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577935","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577935"}}